Background-Emerging evidence suggests that near-roadway air pollution (NRP) exposure causes childhood asthma. Associated costs are not well documented.
Introduction
Approximately 36 million people in the U.S. live within 300 feet of a four-lane highway, railroad, or airport. 1 Emerging evidence suggests that near-roadway air pollution (NRP) exposure causes childhood asthma. 2, 3, 4, 5 A causal relationship implies that any subsequent asthma exacerbation, regardless of its precipitating trigger, can be attributed to NRP exposure. 6 In urban areas in Southern California, NRP exposure may account for a substantial proportion of all air pollution-related exacerbations in children, which are commonly estimated on a population level only for regional pollutants. 7, 8, 9 There has been little study of the costs of NRP-related health effects, 10, 11 which may be substantial. 12 There are three categories of costs associated with these effects: direct costs are payments for healthcare; indirect costs reflect opportunity costs such as lost wages; and willingness to pay (WTP) to avoid the burden of asthma quantifies negative quality-of-life consequences. 13 Population estimates of asthma-related costs have generally not quantified the day-to-day experience of asthma, because no robust studies had appropriately measured it. 14, 15, 16 We developed a model of annual cost of childhood asthma that integrated novel methods from economics and epidemiology including WTP to avoid asthma morbidity 17 and risk assessment incorporating asthma morbidity in children with NRP-attributable asthma. 7 We evaluated the cost of pollution-related childhood asthma in Los Angeles county (LAC) in 2007 and the hypothetical cost per year of pollution-related childhood asthma under alternative levels of regional pollution and exposure to NRP.
LAC has a high prevalence of childhood asthma, 18 dense traffic corridors, and high levels of regional air pollutants such as ozone (O 3 ), nitrogen dioxide (NO 2 ) and particulate matter. These regional levels are expected to continue to decline as a result of regulatory efforts. 19 While a reduction in regional pollution should decrease the cost of asthma, the net impact when that reduction is combined with a change in the proportion of the population living near a major roadway is not obvious. Based on results of a previously published evaluation of pollution-related asthma exacerbations in LAC, 7 we have now estimated (1) the childhood asthma-related costs attributable to regional and near-roadway pollution in 2007 and (2) the savings that might result from a 20% regional pollution reduction combined with a 20% increase or decrease in the proportion of families living in proximity to a major roadway relative to 2007 levels. 7 
Methods

Pollution-attributable asthma outcomes
The selection of pollutants, estimation of population exposure, concentration response functions (CRFs) and pollution-associated burden of asthma have been described previously. 7 Briefly, we examined the effects of O 3 and NO 2 because each has a wellestablished causal relationship with asthma exacerbations. 20, 21 In Southern California, NO 2 may be used as a proxy for general regional pollution (exclusive of O 3 ) including particulate matter, elemental carbon, and nitric acid-all associated with respiratory health effects. 22, 23 O 3 is relatively uncorrelated with other regional pollutants in the Los Angeles air basin. 23, 24 We avoided double counting pollution-attributable exacerbations by evaluating each pollutant separately.
The baseline exposure for all scenarios was the 2007 population-weighted proportion of LAC children living near a major roadway and the 2007 levels of regional pollution. 7 A CRF for NRP was based on residence within 75m of a major roadway, a proxy for NRP exposure relevant for Southern California. 5, 9 Major roadways included freeways, highways or major arterial roads (functional road classes FRC01, FRC03 and FRC04 from the TeleAtlas MultiNet roads network 7 ). In the first scenario, we estimated total asthmaassociated costs of having 17.8% of the population living near major roadways by constructing a hypothetical in which this population's NRP-exposure was reduced to background levels. We examined the costs imposed by the NO 2 and O 3 levels observed in LAC in 2007 as compared to their mean values in cleaner comparison cities in the Southern California Children's Health Study that year (Scenarios 1A and 1B, respectively). The 2007 baseline measures of 24-hr NO 2 across census tracts in LAC ranged from 6.2 to 31.4 ppb (population-weighted mean of 23.3 ppb). In Scenario 1A, we calculated the impact of a reduction in population-weighted NO 2 exposure to 4 ppb across all census tracts. The 2007 baseline measures of 8-hr daily maximums for O 3 across LAC ranged from 30.5 to 55.6 ppb (population-weighted mean of 39.3 ppb). In Scenario 1B, we reduced the populationweighted O 3 exposure to 36.3 ppb. This first scenario generates the full asthma burden of the combined effects of NRP and regional pollution in LAC as compared to cleaner communities.
To illustrate the change in costs with respect to the two components of pollution-attributable asthma, we constructed hypothetical scenarios in which a decline in each regional pollutant was combined with either a 20% decrease (second scenario) or a 20% increase (third scenario) in the population percentage exposed to NRP. Since 17.8% of LAC children live near a major roadway, a change of 20% constitutes 3.56 percentage points. The hypothetical reductions in NO 2 and O 3 concentrations are plausible and based projections in the current air quality plan for Southern California. 19 The health effects and their costs were estimated for a single year. When calculating outcomes in the hypothetical scenarios, we assumed that changes in the prevalence of asthma and resulting exacerbations were fully realized and instantaneous. These assumptions allowed us to compare costs across all of the scenarios and avoided the need for discounting.
For each scenario we used the near-roadway CRF to estimate the prevalence of asthma cases attributable to NRP in a given year. 9 We estimated three types of exacerbations among children in LAC for one year: 7 regional pollution-triggered outcomes among children with NRP-attributable asthma (Box 3, Figure 1 ), outcomes triggered by other factors among children with NRP-attributable asthma (Box 2, Figure 1 ), and regional pollution-triggered outcomes among children with asthma caused by factors other than NRP ("other-cause asthma") (Box 6, Figure 1 ). Asthma exacerbation-related outcomes included: bronchitis episodes, hospital admissions, emergency room (ER) visits, doctor visits, and school absences for respiratory illness (for O 3 only). Bronchitis, defined as a productive cough lasting three months or more, is a sensitive marker of NRP-attributable asthma exacerbations 25 and is distinct from viral or bacterial bronchitis. We estimated the annual frequency of each outcome attributable to these regional pollutants using published CRFs for Southern California children, when available, or other appropriate CRFs when not. Supplement Tables 1 and 3 provide details on the CRFs and the baseline rates.
Direct and indirect costs of an exacerbation
For each individual outcome we estimated the direct cost of goods and services and the indirect cost of caregivers' lost wages. For the direct costs of healthcare, we used the amount charged rather than the amount paid, because amounts charged are not confounded by insurance status. All costs were expressed in 2010 dollars 26 and sources are summarized in Supplement Table 2 .
Direct costs of hospitalization and ER visits were calculated as the sum of facilities and physician charges. 27, 28 The direct cost of an office visit was estimated using the national mean charge for a physician visit. 29 The direct cost of asthma inhalers (rescue and controller medications) was the average of the prices for each inhaler category weighted by the typical utilization of each category. 30 The average price for each category of drug was the weighted mean of the name brand and generic prices. 31, 32 The indirect costs for office visits, ER visits and hospitalizations were the value of the caregiver's time spent traveling, 33 waiting, 34 and receiving care 27, 35, 36 and were taken from secondary databases and peer-reviewed publications. We used one workday (eight hours) as the time for a school absence and valued time at the average wage rate. 37 While this is the standard approach to valuing indirect costs, it overlooks the fact that caregivers of children with asthma sometimes leave the labor force to provide care. 38 These caregivers face lower expected lifetime earnings even when they do return to the labor force. 39 
Direct and indirect costs of routine care
Children with asthma need more routine care than other children. These fixed costs of asthma (Box 1, Figure 1 ) include medication use and treatment for excess ear and sinus infections-an asthma-related comorbidity. The expected quantity for each outcome was estimated for children aged 0-17 in LAC using peer-reviewed literature and secondary databases (Supplement Table 2 ). 30, 40, 41 Costs were calculated using the same approach as for exacerbations.
Direct and indirect costs of a bronchitis episode
Each bronchitis episode includes five potential costs: school absences, 42 antibiotics prescriptions, 43, 44, 45, 46 office visits, 47, 48 ER visits, 47, 48 and inpatient hospital stays. 47, 48 We estimated the number of office visits, ER visits and hospital stays as the mean rate for children with asthma using the 2007 Medical Expenditure Panel Survey. These estimates are significantly lower than some reported rates. 49 
Willingness to pay
Bronchitis and asthma substantially impact quality of life. 13, 49, 50 The value of this impact is quantified as the WTP to avoid this burden, using contingent valuation. A contingent valuation study offers participants a hypothetical health-related product, quotes prices, and inquires about WTP. Surveys must be designed to elicit values specific to desired health outcomes and to ensure valid responses. 16 To meet these criteria we used the results of a contingent valuation study conducted in California among families with children with asthma. 17 The WTP study 17 was designed to estimate a WTP beyond the household's current expenditures and included "debriefing" questions to ensure that the WTP was based on a desire to reduce the pain and suffering of asthma. Thus the estimate is specific to asthma and additive to the other costs. The quality-of-life burden of a single day of symptoms was calculated as the mean WTP divided by the mean number of symptom-days that would have been avoided using the hypothetical product. 17 The hypothetical product offered a 50% reduction in days with asthma symptoms, so we doubled that estimate to determine the WTP to avoid a case of asthma. 17 Using the WTP results, 17 we calculated the quality-of-life value of symptom-days for bronchitis and ear and sinus infections. We multiplied the mean number of symptom-days in excess of those in children without asthma 41 by the WTP to avoid a day with symptoms. 17 The CRF was based on bronchitis lasting at least three months. 25 We used a more conservative value of 35 symptom-days per episode, based on other studies examining the cost of cough lasting more than four weeks. [50] [51] [52] The WTP estimate to assign costs to bronchitis episodes and ear and sinus infections 17 was used because it is specific to children, consistent with our outcome definitions, and meets guidelines for validity. 16 Our WTP estimates for these outcomes are more conservative than values extrapolated from existing literature by the Environmental Protection Agency. 53 
Results
We previously reported detailed estimates of the burden of pollution-attributable asthma in LAC that serve as the basis for our cost estimates. 7 Briefly, we estimated that 27,100 cases of childhood asthma (4,900 to 51,200; 95% CI) are attributable to current NRP exposure, equivalent to 8% of the total current asthma burden in LAC. If proximity to roadways were reduced as in Scenario 2, there would be 5,900 (1,000 to 11,800; 95% CI) fewer cases of childhood asthma; increasing proximity as in Scenario 3 would have the exact opposite effect. Table 1 shows the change in the numbers of exacerbations under each scenario relative to the 2007 baseline. Among children with asthma, substantial proportions of the 2007 burden of bronchitis (57%), hospitalizations (20%), ER visits (11%), doctor visits (12%), and school absences (31%) were attributable to the combined effect of NRP exposure and regional pollution (Scenarios 1A and 1B in Table 1 ). The magnitude of bronchitis episodes attributable to pollution reflects the susceptibility of the population of children with asthma and the prevalence of asthma consequent to NRP-exposure. A reduction in regional pollution and in NRP exposure (Scenario 2) decreases all asthma outcomes; a reduction in regional pollution accompanied by an increase in NRP exposure (Scenario 3) increases all outcomes among those children with asthma due to NRP. Despite the decrease in regional pollution, the increase in cases of asthma due to NRP exposure leads to a net increase in ER visits, doctor visits and school absences (Scenario 3 in Table 1 ). (4)]. The total annual cost of routine care (not including acute exacerbations) plus the quality-of-life cost as measured by WTP is approximately $3,000 for a single asthma case. The cost for a single episode of bronchitis is $1,500.
The cost per year of asthma outcomes attributable to NRP and regional pollution for each scenario is the product of the quantity of each outcome due to pollution in that scenario (Table 1 , column 4) and the cost of each outcome [ Table 2 , sum of columns (2)+(3)+(4)]. Table 3 shows the costs of the bronchitis episodes, hospital admissions, ER visits, doctor visits and school absences (O 3 only) due to regional air pollution for children with asthma due to NRP [Column (1)] and children with other-cause asthma [Column (2)]. Column (3) shows the cost of those outcomes due to triggers other than regional pollution among children with asthma due to NRP. The sum of the cost of these outcomes for NO 2 and exacerbation due to other triggers among those children with NRP-attributable asthma was $123 million [ Table 3 , Row (5), Column (5)]. A large portion ($108 million) is due to the reduction in bronchitis episodes brought on by pollution exposure. The cost of all outcomes among children with NRP-attributable asthma [the sum of the total row for NO 2 in Column (1) of Table 3 , $9m, and the total row for NO 2 in Column (3), $15m], accounted for about 20% of the $123 million total.
The cost of outcomes due to O 3 and exacerbations due to other triggers among children with NRP-related asthma totaled $362 million (Table 3 , Scenario 1B). The differences between Scenario 1B and Scenario 1A are largely due to school absences due to O 3 . Across all O 3 outcomes, 30% of the potential savings were due to reducing exacerbations among children with NRP-attributable asthma. Table 3 illustrate the combined effects of the 20% change in NRP exposure and the 20% reduction in regional pollution. We reported the estimated costs for the regional pollutant most responsible for each outcome: NO 2 for all outcomes except school absences. Thus, if regional pollution were 20% lower than 2007 levels and the proportion of the population near roadways were reduced, there would be a decrease in the frequency of each outcome (from Table 1 , Scenario 2), and a decrease in total costs ( Table 4 shows, for each scenario, the sum of the cost of exacerbations [column (1) , which is the sum of columns (1)+(2)+(3) in Table 3 ] and of routine care for NRP-attributable asthma cases [column (2) ]. Scenarios 1A and 1B in Table 4 reflect the total burden of NRP and regional pollution beyond that of cleaner comparison communities. A 100% reduction in major roadway proximity with a reduction in NO 2 levels to those in clean communities (Scenario 1A) would save approximately $203 million annually. Elimination of NRP proximity and reduction of O 3 to clean community levels (Scenario 1B) would save almost $441 million yearly. In Scenario 1A, 39% of the total cost of the current burden of NRP and regional NO 2 is due to the cost of routine care for NRP-attributable asthma cases (the analogous figure for O 3 is 18%). These NRP fixed costs have not been considered in previous regulatory risk assessments. The total cost savings achieved by reducing both regional pollution and proximity exposure (Scenario 2) are approximately $84 million; in comparison, increasing NRP exposure while reducing regional pollution provides a cost savings of only $2 million (Scenario 3). Thus, Scenario 3 suggests that the cost of the increased number of asthma cases due to NRP-attributable asthma eliminates almost all the savings of reducing regional pollution.
Scenarios 2 and 3 in
The asthma-related impact of NRP is the sum of the cost of all exacerbations among children with NRP-attributable asthma [columns (1) and (3) from Table 3 ] and the cost of routine care for NRP-attributable cases [column (2) from Table 4 ]. Thus, if NRP exposure were eliminated, $104 and $189 million could be saved, respectively, by also reducing NO 2 and O 3 to levels in clean communities.
Discussion
The cost of air pollution-attributable childhood asthma is large-between $203 (for NO 2 ) and $441 million (for O 3 ) in 2007. For perspective, that was 6% and 13%, respectively, of the health department's total expenditures on all health services for uninsured residents in LAC. 54 A 20% decrease in regional pollution accompanied by a 20% decrease in the proportion of children living near major roads would reduce the cost of asthma by approximately $81 million more than if that decrease in regional pollution were accompanied by a 20% increase in the proportion of the population living near major roads. If policies such as replacing automobiles with electric vehicles or creating buffers between major roadways and children's homes and schools are effective in eliminating cases of asthma attributable to traffic proximity exposure, the reduction in the total cost of the combined pollution-attributable burden would be 51% for NO 2 and 43% for O 3 .
Expenditures to cover the direct costs of asthma represent a loss to society. In Los Angeles, 32% of children are covered by public insurance (Medi-Cal or Healthy Families); 55 therefore, public funds pay for 32% of the direct pollution-attributable costs of asthma ($34 million a year for NO 2 ). If this public expenditure were eliminated, that money could be used to extend Medi-Cal insurance to an additional 33,700 children each year (based on the cost of coverage and average healthcare expenditures 56 ). Two doses of varicella vaccinations could be provided to an additional 135,218 children each year. 57 If we invested the recovered funds in education, then full-time pre-school could be provided for an additional 2,358 children, producing a societal benefit of $49 to $132 million a year (based on returns to investment in early education 58 ).
Our methodology relied on two key assumptions. First, we assumed that without exposure to NRP, the child would not have developed asthma. Some of these children might have nonetheless developed asthma due to other risk factors, which would render our costs an overestimation. Second, we assumed that the CRF of proximity would be the same under alternative hypothetical scenarios, but the effects of traffic-proximity as a proxy for NRP are likely to decrease if average vehicle emissions decrease in the future.
There are additional uncertainties in estimating costs. Based on the previously estimated burden of disease, 7 we accounted for statistical uncertainty. Actual prices charged for healthcare vary over individuals; thus we used average estimates of charges. We also assumed that an NRP-attributable asthma case requires the same level of routine care and treatment for comorbidities as asthma due to other causes.
We assumed that outcomes associated with NO 2 and O 3 might affect the same individuals, and we did not sum the costs associated with each of these pollutants. In addition, some studies suggest that exposure to NO 2 may potentiate the effect of O 3 , 59 or that prior O 3 exposure may exacerbate the effects of NRP in diesel exhaust. 60 Therefore, these estimates would underestimate costs if the effects were additive. Last, we may have underestimated the total costs of pollution-related asthma because we omitted the costs associated with adult asthma.
Conclusions
By properly accounting for the effects of both NRP and regional pollution on asthma exacerbations, we identified large and previously unappreciated costs. Disaggregating the effects of regional pollution and NRP exposure helps clarify the health co-benefits and cost savings that could be achieved by reducing exposure to both regional and near-roadway pollution. Although our results are specific to LAC, they are relevant to other large metropolitan areas because of the large numbers of children living near major roadways across the U.S. [1] [2] 61 Key messages
• The annual cost of asthma in Los Angeles County attributable to O 3 is approximately $441 million and to NO 2 approximately $202 million.
• Routine care for children with asthma attributable to near-roadway pollution was 18% of the combined NRP and O 3 cost and 39% of the combined NRP and NO 2 cost.
• NPR-attributable asthma accounted for 20% (NO 2 ) to 30% (O 3 ) of the cost of exacerbations due to pollution.
• The cost of near-roadway pollution (NRP) accounted for 51% of total asthmarelated cost due to NRP and regional NO 2 , and 43% of the total due to NRP and O 3 .
• Cost of routine asthma care was almost $3,000 yearly for each child.
• The actual public expenditures in 2007 on the asthma-related burden of pollution could have provided public insurance to 33,000 children, or 135,000 varicella vaccinations, or full-time preschool for 2,000 children. Outcomes Associated with Exacerbations and Routine Care Attributable to Pollution Table 1 Decrease [increase in brackets] in the number of asthma outcomes under different exposure scenarios relative to baseline NRP exposure and regional pollution Table 2 Costs of routine asthma care for a single case of asthma and a single bronchitis episode (in 2010 US $)
Annual cost for routine asthma case
Mean annual occurrence (1) Direct cost per occurrence Values within brackets are increases in costs. In scenarios 2 & 3, the pollution change is for NO 2 for all outcomes except for school absences, for which we used O 3 . The cost of routine care is the cost for a case (Table 2) multiplied by the change in number of cases attributable to NRP exposure (decrease of 27,100 for Scenarios 1A and 1B, increase of 5,900 for Scenario 2, and decrease of 5,900 for Scenario 3). Values may not sum due to rounding.
